Aapro, M., Karthaus, M., Schwartzberg, L., Bondarenko, I., Sarosiek, T., Oprean, C., . . . Rugo, H. (2017). NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: Results of a randomized, double-blind, phase 3 trial versus oral palonosetron.
Cita Chicago Style (17a ed.)Aapro, Matti, et al. NEPA, a Fixed Oral Combination of Netupitant and Palonosetron, Improves Control of Chemotherapy-induced Nausea and Vomiting (CINV) over Multiple Cycles of Chemotherapy: Results of a Randomized, Double-blind, Phase 3 Trial Versus Oral Palonosetron. 2017.
Cita MLA (9a ed.)Aapro, Matti, et al. NEPA, a Fixed Oral Combination of Netupitant and Palonosetron, Improves Control of Chemotherapy-induced Nausea and Vomiting (CINV) over Multiple Cycles of Chemotherapy: Results of a Randomized, Double-blind, Phase 3 Trial Versus Oral Palonosetron. 2017.